Abstract: The present invention is in the field of emulsifiers and provides novel emulsifier mixtures for use in cosmetic or pharmaceutical formulations or in detergents. The emulsifier mixtures according to the invention comprise a citrate ester mixture and at least one 1,2-alkanediol, 1,3-alkanediol, 1,4-alkanediol and/or 1,5-alkanediol and are characterized by increased stability and low precipitation over a wide temperature range and during a long storage period.

Abstract: The present invention primarily relates to a fatty acid ester or mixture of two or more fatty acid esters or mixture comprising one or more fatty acid esters, wherein the fatty acid ester or one, two, three or more, preferably all, of the fatty acid ester(s) is/are selected from the group consisting of 3-hydroxypropyl caprylate, glyceryl monocaprylate, 3-hydroxypropyl undecylenate and glyceryl monoundecylenate, for use in the treatment of an excess of Malassezia on the skin surface of mammals, preferably of humans. The present invention further relates to particular mixtures or products, and to the cosmetic, non-therapeutic use of fatty acid esters or of mixtures or products comprising fatty acid esters as defined herein to reduce the amount of Malassezia on the skin surface of mammals, preferably of humans.

Abstract: The present invention primarily relates to the use of a fatty acid ester, or a mixture comprising, or consisting of, two or more fatty acid esters, in a cosmetic product for inhibiting growth of microorganisms on a mammal's skin or mucosa, and/or preserving the cosmetic product against microbial growth, wherein the fatty acid ester, or at least one of the two or more fatty acid esters in the mixture, is selected from the group consisting of 3-hydroxypropyl caprylate, 3-hydroxypropyl undecylenate and glyceryl monoundecylenate.

Abstract: A topical composition comprising a synthetic compound that is an ester of sinapinic acid, a method for treating skin to provide one or more benefits selected from (a) protecting against UV radiation, (b) inhibiting DNA damage in skin cells, (c) inhibiting skin inflammation, and (d) scavenging free radicals by topically applying a composition containing the synthetic compound and a method for synthesizing the compound.